SPATA4: A Protein Targeted for Alzheimer's and Other Neurological Disorders

Target Name: SPATA4

NCBI ID: G132851

SPATA4

SPATA4: A Protein Targeted for Alzheimer's and Other Neurological Disorders

SPATA4 (SPEF1B) is a protein that is expressed in the brain and is known for its role in the development and progression of several neurological disorders, including Alzheimer's disease. The protein is a key regulator of the synaptic plasticity, which is the ability of the brain to change and adapt throughout a person's life.

Recent studies have identified SPATA4 as a potential drug target for the treatment of Alzheimer's disease. By blocking the activity of SPATA4, researchers have found that they can reduce the formation of beta-amyloid plaques, which are a hallmark of Alzheimer's disease, and improve cognitive function in animal models of the disease.

SPATA4 is also a potential biomarker for Alzheimer's disease. By measuring the level of SPATA4 in brain tissue, researchers can monitor the progression of the disease and identify potential drug targets. This is an important step in the development of new treatments for Alzheimer's disease, as it allows researchers to understand how the disease progresses and to identify areas where new treatments can be developed.

In addition to its potential as a drug target and biomarker, SPATA4 is also of interest to researchers because of its role in the development of other neurological disorders. Studies have shown that SPATA4 is involved in the development of neurodegenerative diseases, including Parkinson's disease and Huntington's disease. This suggests that SPATA4 may be a useful target for the development of new treatments for these disorders as well.

Overall, SPATA4 is a protein that is of great interest to researchers because of its role in the development and progression of neurological disorders. By blocking the activity of SPATA4, researchers have found that they can reduce the formation of beta-amyloid plaques and improve cognitive function in animal models of Alzheimer's disease. Additionally, SPATA4 is a potential biomarker for the disease and may be a useful target for the development of new treatments for other neurological disorders. Further research is needed to fully understand the role of SPATA4 in neurological disease and to develop new treatments.

Protein Name: Spermatogenesis Associated 4

Functions: May play a role in apoptosis regulation

The "SPATA4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SPATA4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets